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Whether the brain tumor medulloblastoma originates from stem cells or restricted progenitor cells is unclear.
To investigate this, we activated oncogenic Hedgehog (Hh) signaling in multipotent and lineage-restricted
central nervous system (CNS) progenitors.We observed that normal unipotent cerebellar granule neuron pre-
cursors (CGNPs) derive from hGFAP+ andOlig2+ rhombic lip progenitors. Hh activation in a spectrum of early-
and late-stage CNS progenitors generated similar medulloblastomas, but not other brain cancers, indicating
that acquisition of CGNP identity is essential for tumorigenesis. We show in human and mouse medulloblas-
toma that cells expressing the glia-associated markers Gfap and Olig2 are neoplastic and retain features of
embryonic-type granule lineage progenitors. Thus, oncogenic Hh signaling promotes medulloblastoma from
lineage-restricted granule cell progenitors.INTRODUCTION
It has been proposed that cancer can be viewed as aberrant or-
ganogenesis initiated by a multipotent or restricted progenitorcell that acquires infinite capacity for self-renewal through accu-
mulated mutations (Reya et al., 2001). Principles of normal he-
matopoietic stem cell development (Barabe et al., 2007; Coba-
leda et al., 2007) have provided insight into the mechanisms ofSIGNIFICANCE
Cancer stem cells have been proposed as therapeutic targets in human brain cancer. Although such populations have been
reported in medulloblastoma, tumor progenitor origins remain unclear. Here we show that medulloblastoma is generated
from cells related to several stages of cerebellar granule neuron precursor (CGNP) development and that some tumor cells,
demonstrable in murine models and human medulloblastoma, retain primitive features analogous to precursors of the em-
bryonic brain. These data highlight the importance of a developmental perspective in understanding cells involved in central
nervous system tumor progression and the histopathological composition of brain cancers. They suggest that a potential
therapeutic target is the process regulating acquisition of CGNP phenotype.Cancer Cell 14, 123–134, August 12, 2008 ª2008 Elsevier Inc. 123
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Cellular Origins of MedulloblastomaFigure 1. Identification of an Olig2+ Progen-
itor Population in the Rostral RL
(A) The cerebellar anlage at E14. The ventricular
zone (VZ) and rhombic lip (RL) serve as mitotic
niches at this age. The external granule layer
(EGL) is formed by proliferating cerebellar granule
neuron precursors (CGNPs) that have left the RL.
CP, choroid plexus; IGL, internal granule layer.
(B) At postnatal day 7 (P7), the developing cerebel-
lum (CB) is divided into ten lobes with defined cor-
tical layers. ML, molecular layer; PL, Purkinje cell
layer; WM, white matter; GNP, granule neuron pre-
cursor; IN, interneuron; BG, Bergmann glia; PN,
Purkinje neuron; AS, astrocyte; OL, oligodendro-
cyte.
(C–E) Sagittal sections at embryonic day 14 (E14)
in hGFAP-cre mice showing colocalization of nes-
tin, Cre, and Pax6 proteins in progenitor cells of
the VZ and rostral rhombic lip (rRL).
(F) Olig2 expression is largely restricted to the dor-
sal rRL.
(G and H) Fate-mapping experiments (hGFAP-cre
3 ROSA26-eYFPflox/flox mice) reveal yellow fluo-
rescent protein (YFP) in the EGL and a subset of
RL cells that express Olig2 (arrows).
(I) Olig2+ RL precursors colabel with the CGNP
marker Pax6; some single Pax6+ precursors in
the VZ were observed (arrows).
(J) Summary of cells in the rRL region at E14 show-
ing relative positions of radial glia (yellow and
green), Pax6+ (light blue and dark blue), Olig2+
(red), and Pax6+Olig2+ (purple) cells.self-renewal and multilineage differentiation in hematopoietic
malignancies (Faber and Armstrong, 2007; Warner et al., 2004).
However, for most organ systems, parallels between normal
stem cell development and solid tumor formation remain poorly
understood.
The central nervous system (CNS), with its highly diversified
classes of neuronal and glial progenitor cells, provides a suitable
model to study such mechanisms. Several studies have docu-
mented the existence of cancer stem cells for glioma and the
cerebellar tumor medulloblastoma (MB) with properties reminis-
cent of normal neural precursors (Singh et al., 2004; Galli et al.,
2004; Hemmati et al., 2003). Expression profiling has indicated
correlations between specific stages of cerebellar development
and MB (Lee et al., 2003; Kho et al., 2004). The Sonic hedgehog
(Shh) pathway has critical functions in cerebellar development,
and mutations of this pathway are etiologic in MB (Pietsch
et al., 1997).
The cerebellum (CB) develops from several progenitor re-
gions, the rostral rhombic lip (rRL) and cells of the ventricular
zone (VZ) surrounding the IVth ventricle (Altmann and Bayer,
1997; Morales and Hatten, 2006; Kawauchi et al., 2006; Casper
and McCarthy, 2006; Malatesta et al., 2003) (Figure 1A). The VZ
of the cerebellar anlage generates Purkinje neurons (PNs), inter-
neurons (INs), and glial cells. Progenitors within the rRL express
the radial glial markers RC2 and nestin and give rise to all granule
lineage cells (GCs) of the external granule layer (EGL) and internal
granule layer (IGL). We recently reported that cells that express
Cre recombinase under control of human regulatory sequences124 Cancer Cell 14, 123–134, August 12, 2008 ª2008 Elsevier Inc.for glial fibrillary acidic protein (hGFAP) are most probably radial
glia and generate most cerebellar cell types, including cerebellar
granule neuron precursors (CGNPs) (Spassky et al., 2008). Sub-
sequently, CGNPs migrate rostrally along the surface of the cer-
ebellar anlage to form the EGL (Lee et al., 2005; Machold and
Fishell, 2005; Wang et al., 2005) (Figure 1A).
PNs (Figure 1B) produce Shh, which binds the transmembrane
protein repressor Patched (Ptc), relieving inhibition of Smooth-
ened (Smo) activity, which is essential for CGNP proliferation in
the EGL (Wechsler-Reya and Scott, 1999; Dahmane and Altaba,
1999; Lewis et al., 2004). CGNPs of the EGL gradually show re-
duced proliferation levels, migrate internally, and differentiate
into glutamatergic neurons in the IGL (Figure 1B), a process
that is largely completed by postnatal day 15 (P15) in mice (Bor-
ghesani et al., 2002), and by about one year of age in the human
CB (Abraham et al., 2001). Transcriptional control of CGNP de-
velopment involves functions of the bHLH protein Math1 (Ben
Arie et al., 1997; Machold and Fishell, 2005; Wang et al., 2005)
and the homeodomain protein Pax6 (Engelkamp et al., 1999;
Yamasaki et al., 2001).
Inherited activating mutations of the Shh/Smo pathway in hu-
mans are etiologic in MB, but not in glioma (Hahn et al., 1999;
Johnson et al., 1996). This cancer spectrum is faithfully modeled
in the CNS of mice heterozygous for a mutation of the Hedgehog
(Hh) pathway suppressor Ptc (Johnson et al., 1996) or express-
ing an activated allele of Smoothened (SmoM2) (Mao et al.,
2006), supporting the proposal that CGNPs are particularly sus-
ceptible to transformation by oncogenic Hh signaling (Shih and
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Cellular Origins of MedulloblastomaFigure 2. A Subset of Cerebellar Granule
Neurons Derive from Olig2+ Progenitors
(A) The Olig2-tva-cre allele and genotyping of the
respective mutant mice using PCR to generate
wild-type 429 bp and mutant (cre) 446 bp prod-
ucts.
(B–I) Fate mapping of Olig2-expressing cells with
the ROSA26-eYFPflox/flox reporter. Colocalization
of YFP and Olig2 proteins in sagittal sections of
P7 cerebella reveals that YFP is expressed in oli-
godendrocytes within the cerebellar WM (yellow
arrows in C) as well as in occasional cells within
the EGL (white arrows). YFP/Pax6 labeling con-
firms the granule lineage character of YFP-ex-
pressing EGL cells (D, arrows in E). The IGL of
P21 cerebella demonstrates lobe-specific differ-
ences in Olig2 fate mapping.
(G) The IGL of lobe II contains YFP+ cells that pre-
dominantly coexpress Olig2 (arrow and inset) but
not the granule lineage cell (GC) marker Zic.
(H) In contrast, the IGL of lobe X contains numerous
YFP/Zic double-positive cells (arrow and inset).
(I) Mean percentage (±SEM) of Olig2/YFP and Zic1/
YFP double-positive cells in the IGL of lobe II and X.
(J–M) In utero fate mapping of Olig2-expressing
cells by RCAS-GFP virus injection into the rRL of
E15.5 Olig2-tva-cre mice. Analysis of the CB at
P7 reveals GFP to be expressed in Olig2+ (K) WM
cells, as well as in Pax6+ (L) and Zic+ (M) cells of
the IGL in lobe X.Holland, 2004). Nevertheless, the cellular origins of MB from uni-
potent precursors in the EGL remain controversial. The identifi-
cation of multipotent MB stem cells (Hemmati et al., 2003; Singh
et al., 2004) capable of multilineage differentiation, in particular,
has challenged the hypothesis of a unipotent cell of origin. To in-
vestigate these issues, we defined distinct progenitor popula-
tions for CGNPs within the rRL as well as in the EGL and system-
atically assessed their tumorigenic potential with respect to Hh
signaling.
RESULTS
Olig2 Expression Identifies RL Progenitors for a Subset
of Granule Cell Neurons
In order to determine possible parallels between progenitors
during cerebellar development and tumorigenesis, we first char-
acterized relevant embryonic hindbrain VZ and rhombic lip (RL)
populations. Nuclei of cells that express Cre proteins in
hGFAP-cre mice are observed along the VZ and the ventral as-
pect of the rRL of the midline cerebellar anlage at E14.5 (Figures
1C–1E). Cre proteins in these mice mark nestin+ cells that have
been proposed to be radial glia of the rRL that give rise to CGNPs
(Spassky et al., 2008), which show robust Pax6 expression. We
next investigated expression of the bHLH protein Olig2, which
marks multilineage progenitor populations of the forebrain and
the spinal cord (Petryniak et al., 2007; Lu et al., 2002; Zhou
and Anderson, 2002). Olig2 expression identified a distinct cell
population predominantly restricted to the rRL and extending
to the boundary of the EGL (Figure 1F). The cerebellar VZ con-
tained rare Olig2+ cells, and expression of Olig2 was rapidly
downregulated within the EGL.To establish a possible lineage relationship between hGFAP-
cre and Olig2+ cells, we fate mapped hGFAP-cre-expressing
precursors with a conditional ROSA26-eYPFflox/flox reporter (Sri-
nivas et al., 2001). As shown (Figure 1G, white line), hGFAP-cre-
expressing precursors give rise to the majority of CGNPs of the
primitive EGL and some Olig2+ cells of the rRL (Figure 1H).
Most Olig2+ cells in the rRL coexpressed the CGNP marker
Pax6 (Figure 1I), while Olig2 expression was gradually lost
and Pax6 was retained as CGNPs migrated into the EGL.
Olig2+Pax6+ cells could be identified within the rRL and EGL
until E18.5 but were never observed at P7 or later stages (data
not shown; see also below).
To establish Olig2+ progenitor contributions during CGNP de-
velopment, we constructed a multifunctional mouse line by in-
serting tva, an avian-specific retroviral receptor, and an IRES-
cre recombinase cassette into the endogenous Olig2 locus by
homologous recombination (Figure 2A). When Olig2-tva-cre+/
mice were crossed to ROSA26-eYFPflox/flox conditional reporter
mice, we found that 98% of YFP+ cells in the P7 cerebellar white
matter (WM) expressed Olig2, consistent with oligodendroglial
identity (Figures 2B and 2C, yellow arrows). At P21, most of
these cells coexpressed myelin basic protein, and we observed
small numbers of YFP+ PNs and INs (see Figures S1E and S1F
available online). At P7, we detected a small subpopulation of
YFP+ CGNPs within the EGL, confined mainly to posterior cer-
ebellar lobes IX and X (Figures 2C–2E, white arrows). At P21,
we observed fate mapping to GCs within the IGL (Figures 2F–
2I). Interestingly, only 3% of YFP+ cells expressed the GC
marker Zic in the lobe II IGL, but 58% of YFP+ cells were double
positive in lobe X (Figures 2G and 2I), indicating that Olig2
contributions to GCs of the IGL are restricted mainly to the
posterior lobes.Cancer Cell 14, 123–134, August 12, 2008 ª2008 Elsevier Inc. 125
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Cellular Origins of MedulloblastomaFigure 3. Development of Medulloblastoma
but Not Glioma from hGFAP+ and Olig2+
Precursors
(A–H) Targeting hGFAP+ and Olig2+ precursor
cells with SmoM2 results in medulloblastoma
(MB). While neoplastic transformation of hGFAP+
cells affects the entire cerebellar cortex (A–D),
MBs from Olig2-expressing precursors are re-
stricted to posterior cerebellar regions (E–H). Al-
though hGFAP-cre and Olig2-cre are broadly
expressed in all parts of the central nervous sys-
tem, neoplastic lesions due to SmoM2 are re-
stricted to the CB.
(I–L) Forebrain sections including the subventricu-
lar zone (SVZ) in adult animals appear normal.
(M–P) Transplantation of Olig2-tva-cre:SmoM2
tumor cells into SCID mice gives rise tumors
both in hindbrain (M and N) and forebrain (O and
P) regions.
(A), (E), and (I)–(P) are frontal sections; (B)–(D), (F)–
(H), (N), and (P) are sagittal sections stained with
hematoxylin and eosin. (C) and (D) are high-power
magnifications of (B), as are (G) and (H) from (F).
Asterisks mark lateral ventricles in (I), (K), and (O)
and the IVth ventricle in (M). BS, brainstem.We found Olig2+ cells in the rRL from E14.5 to E18.5 (Figure 1;
data not shown). To test whether these cells in particular were
a source of lobe IX/X CGNPs, we injected the rRL of E15.5
Olig2-tva-cre+/ animals with an avian retrovirus (RCAS-GFP)
that can only transduce tva-expressing cells (Figure 2J). Fate-
mapping results analyzed at P7 indicated that infected rRL
Olig2-tva+ cells generate Pax6+ CGNPs of the EGL and Zic+
GCs within the IGL (Figures 2K and 2M; Figure S1) of lobes IX
and X. Taken together, these data indicate that Olig2+ progeni-
tors of the rRL make restricted contributions to the GC lineage,
particularly in posterior lobes of the CB.
Smoothened Activation within CNS hGFAP+ and Olig2+
Progenitors Produces Only Medulloblastoma
To determine the significance of hGFAP- and Olig2-expressing
progenitor populations for CNS tumorigenesis, we used
hGFAP-cre and Olig2-tva-cre drivers, respectively, to condition-
ally express an activated Smo (SmoM2) allele fused with YFP se-
quences (Mao et al., 2006). All hGFAP-cre:SmoM2 mice devel-
oped diffuse tumors with the characteristic ‘‘small round blue
cell’’ histology of MB (Figures 3A–3D; Table 1). Olig2-tva-cre:
SmoM2 mice developed tumors with similar histology, except
that they were focal, localized to the posterior-lateral lobes,
and had significantly (p < 0.01) later mortality (Figures 3E–3H; Ta-
ble 1), which was likely a result of their focal nature and the small
numbers of CGNPs targeted by Olig2-tva-cre.
Although hGFAP+ and Olig2+ progenitor populations give rise,
collectively, to CGNPs as well as INs, astrocytes (ASs), and oli-
godendrocytes (OLs), we only observed cerebellar tumors with
histological features of MB. Additionally, activated Hh signaling
in cerebellar PNs driven by Shh-creERT2 did not result in MB
(Table 1). These data demonstrate that hGFAP+ andOlig2+ multi-
potent progenitor populations can produce MB.
Hh signaling can have mitogenic effects in the spinal cord and
forebrain (Mao et al., 2006; Rowitch et al., 1999; Fuccillo et al.,126 Cancer Cell 14, 123–134, August 12, 2008 ª2008 Elsevier Inc.2006), and roles in forebrain glioma have been reported (Clem-
ent et al., 2007; Ehtesham et al., 2007). However, no evidence of
gliomas or other primitive neuroectodermal tumors (PNETs) in
the forebrain was observed despite forced expression of
SmoM2 in the subventricular zone (SVZ), in NG2+ progenitors,
and in oligodendrocyte precursor cells (OPCs) of the forebrain
(Figures 3I–3L; Table 1). Together, these data indicated a hind-
brain- as well as a CGNP/lineage-restricted oncogenic re-
sponse to Hh signaling and raised the question of whether
this is determined by the particular environmental niche of the
EGL. To assess this, we transplanted freshly dissociated cells
from Olig2-tva-cre:SmoM2 tumors into the forebrains and cere-
bella of SCID mice. Tumors formed equally well in both loca-
tions (Figures 3M–3P; Table 1), suggesting that tumor propaga-
tion is governed primarily by cell-intrinsic factors rather than
environment.
Unipotent CGNPs Are Competent to Produce
Medulloblastoma
In myeloid oncogenesis, multipotent cells rather than more re-
stricted progenitor cells are thought to be the origin of leukemia
stem cells (Faber and Armstrong, 2007). To test whether a re-
stricted neuronal precursor can also give rise to MB, we acti-
vated SmoM2 in committed CGNPs. Math1-cre drives expres-
sion within CGNPs of the rRL and the entire EGL until P7–10,
but not in PNs, ASs, or INs (Machold and Fishell, 2005; Wang
et al., 2005). In contrast, expression of the transcription factor
Tlx3 (Hox11L2) is seen only in the EGL of lobes VI–IX, but not
in other lobes or the rRL (Figure S2). Transgenic Math1-cre
mice were generated using regulatory sequences 4 kb upstream
of Math1 (Matei et al., 2005), and Tlx3-cre mice were generated
by gene targeting of Tlx3 (Xu et al., 2008). Fate-mapping crosses
involving a conditional ROSA26-eYFPflox/flox reporter confirmed
that Math1+ and Tlx3+ precursors contributed solely to the GC
lineage (Figures 4A–4H; data not shown).
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Cellular Origins of MedulloblastomaTable 1. Summary of Phenotypes from Crosses of Various cre Drivers with SmoM2flox/flox Mice
Genotype Transgene Type n
MB Formation
(%)
Average Survival
(Days) Tumor Location
Cerebellar Cell
Types Targeted
Math1-cre transgenic 63 100 41 diffuse CGNPs (all lobes),
deep cerebellar nuclei
Tlx3-cre knockin 37 100 45 lobes VI–IX lobe VI–IX CGNPs
Shh-creERT2 transgenic 10 0 NA NA Purkinje neurons
hGFAP-cre transgenic 12 100 33 diffuse radial glia,
all CGNPs, interneurons,
forebrain stem cells,
astrocytes
Olig2-tva-cre knockin 11 100 57 posterior-lateral rostral rhombic
lip progenitors, lobe X
CGNPs, oligodendrocyte
precursor cells, NG2 cells,
interneurons
Gli1-creERT2 transgenic 10 40 102 focal CGNPs, Bergmann glia
Olig2-tva-cre:SmoM2 transplant 5 NA 47 forebrain/hindbrain NA
Math1-cre:SmoM2 transplant 3 NA 84 hindbrain NA
The various cre drivers used, number of crosses performed, average onset of tumor-associated premorbid state, tumor location, and cells initially tar-
geted by Cre recombinase are indicated. Tamoxifen induction was performed in Shh-creERT2 andGli1-creERT2 mice at P10. Results of allotransplan-
tation ofOlig2-tva-cre:SmoM2- andMath1-cre:SmoM2-derived tumors are indicated. NA, not applicable; CGNP, cerebellar granule neuron precursor.When crossed with SmoM2flox/flox mice, all Math1-cre animals
developed MBs that could be transplanted into the cerebella of
SCID mice (Figures 4I and 4J; Table 1; see also Yang et al.
[2008] in this issue of Cancer Cell). Tlx3-cre:SmoM2 animals de-
veloped tumors in a posterior distribution in accord with the Tlx3
expression domain (Figures 4K and 4L). These data show that
unipotent CGNPs are capable of tumor formation when targeted
with oncogenic SmoM2. The Shh transcriptional target Gli1 is
expressed in proliferating CGNPs (Wechsler-Reya and Scott,
1999), and we could induce MB formation in Gli1-creERT2:
SmoM2mice until P14, but not at later postnatal stages (Table 1).
Medulloblastomas Exhibit a Common Phenotypic
Endpoint despite Diverse Cellular Origins
To determine whether significant cellular (i.e., glial and neuronal
diversity) and gene expression differences might exist in tumors
derived from multipotent (e.g., hGFAP-cre) versus unipotent
(e.g., Math1-cre) progenitor populations, we performed Affyme-
trix gene expression profiling analyses, previously demonstrated
to aid in distinguishing MB from other histologically similar
PNETs (Pomeroy et al., 2002). Comparison of expression profiles
of the different murine tumors and Ptc+/ MB using principal
component (PC) analysis confirmed that all tumors had a gene
expression signature of MB and were highly related to each other
(Figure 5A). Along the PC1 coordinate—the direction of greatest
transcriptomic sample variance in cerebellar development—
centroids of the MB tumor profiles were significantly different
from matched normal samples (p < 106). However, PC1 coordi-
nate centroids were not significantly different for tumors derived
from early (i.e., hGFAP-cre or Olig2-cre) versus late/unipotent
(i.e., Math1-cre or Tlx3-cre) GC lineage progenitors (Figure S3).
In fact, only a very small number of genes (150 of 54,675
probes tested) were found to be uniquely and differentially ex-
pressed in each tumor subgroup. In line with this, extensive his-tological (Figures 3C and 3G; Figures 4J and 4L) and immunohis-
tochemical analysis (Figure 5B) failed to reveal any clear
differences in the cellular composition of the tumors. Further-
more, hierarchical cluster analysis based on the 150 genes dif-
ferentially expressed among the tumors did not show strict clus-
tering of tumors based on cell of origin (Figure S4). Together,
these findings indicate that tumors derived from early (i.e.,
hGFAP-cre or Olig2-cre) or late/unipotent (i.e., Math1-cre or
Tlx3-cre) GC lineage progenitors arrive at a common phenotypic
endpoint.
Cells Expressing Gfap and Olig2 in Hh-Activated
Medulloblastomas Are Neoplastic
All mouse tumors analyzed exhibited histological features in
common with some human MBs, including expression of
CGNP markers (Math1, Zic, and Pax6); Gfap, a marker usually
found to be expressed in ASs; and Olig2, which is required for
OL development (Lu et al., 2002; Figure 5B). Clinical symptoms
of tumor burden in Math1-cre:SmoM2 tumors developed at an
average age of 41 days (Table 1); however, we found evidence
of hyperplasia in the EGL at P0 and more clearly at P7 (Figures
6A and 6C). Strikingly, high expression of Olig2 was also found
in these regions (Figures 6B and 6D). At P7, when the EGL is
clearly discernable, excessive numbers of Olig2+ cells were ob-
served in the EGL but not the RL of Math1-cre:SmoM2 mice
(Figure 6D). Indeed, although Olig2+ cells that coexpressed
Pax6 (Figure 1I) or a Math1 proxy marker (Figure 6E) could be ob-
served at antenatal stages until E18, such colabeled cells were
not detectable at P7 (Figure 6F) or later stages. Thus, persistent
Olig2 expression in the EGL of Math1-cre:SmoM2 mice repre-
sents an early molecular marker of a preneoplastic state.
We found that only about 2% of mitotically active phospho-
H3+ (p-H3) cells were Olig2+ in fully developed Math1-cre:
SmoM2 tumors (Figure 6G). Indeed, the vast majority ofCancer Cell 14, 123–134, August 12, 2008 ª2008 Elsevier Inc. 127
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Cellular Origins of Medulloblastomaproliferating cells were Cre+ (Figure 6H), a proxy for Math1 ex-
pression, indicating that most cells contributing to MB growth
are CGNP-like. In human tumors, it is controversial whether cells
expressing GFAP (or OLIG2) comprise the tumor or, alterna-
tively, represent intermingled cells from the normal brain. This
is a critical point given that glial differentiation within MB would
provide further evidence for a multipotent stem cell-like progen-
itor. To establish the nature of cells comprising MB, we dissoci-
ated Math1-cre:SmoM2 tumors and found that the SmoM2-
YFP fusion protein, a marker of cells bearing the tumorigenic
mutation, colocalized in cells expressing Pax6, NeuN, Gfap, or
Olig2. Quantification revealed that YFP proteins colocalized
with most if not all Pax6+, Olig2+, and Gfap+ (100%, 90%, and
96%, respectively) cells in acutely dissociated tumors (Figures
6I–6L). In addition, we identified Olig2+ and Gfap+ cells that
coexpressed the YFP reporter in vivo (Figures 6M and 6N).
Thus, Olig2+ and Gfap+ cells are tumor cells rather than infil-
trated/normal glial cells.
The Gfap+ and Olig2+ cells might represent simple astroglial
and oligodendroglial tumor components. However, examination
of Gfap+ and Olig2+ cells of the cerebellar anlage (Figure 1) sug-
gested that such tumor cells could, alternatively, retain features
of primitive CGNPs. In support of the latter possibility, we found
that 81% of Olig2+ cells expressed Pax6 and that 100% of Gfap+
cells expressed Pax6 in acutely disassociated Math1-cre:
SmoM2 tumors in vitro (Figures 6O and 6P). These findings indi-
cate that cells with an immature/progenitor phenotype are
present in Hh-activated MB.
Human Medulloblastomas Contain Rare OLIG2+ Cells
with Progenitor Features
In order to determine the significance that our findings might
have for human MB, we examined OLIG2+ cell populations within
a cohort of human MBs. Although our original findings in mice
were all in the setting of Shh/Smo pathway activation, we found
that OLIG2+ cells were present in both classic (40%) and desmo-
plastic (Shh-related) (77%) subtypes of human MBs (Figures 7A–
7D; Table S1) and comprised less than 5% of cells in all tumors.
Figure 4. Late-Stage Unipotent CGNPs Are Compe-
tent to Produce Medulloblastoma
(A–H) Cre expression driven by Math1 or Tlx3 promoter se-
quences is normally restricted to GCs, as shown by crosses
with ROSA26-eYFP conditional reporter mice.
(C, D, and G) GCs fate mapped by Tlx3-cre are restricted to
lobes VI–IX.
(F and H) In contrast, calbindin-expressing Purkinje neurons
do not derive from Math1+ or Tlx3+ precursors.
(I–L) Both Math1+ and Tlx3+ granule neurons give rise to MB
after activation of SmoM2, and Tlx3-cre-driven tumors obeyed
posterior restriction consistent with fate mapping (compare
arrows in C and K).
Fluorescence in situ hybridization (FISH) analysis
showed that OLIG2+ cells in human MB contained
copy-number gain at the c-MYC locus, confirming
these as tumor cells and arguing against the possi-
bility that they might represent intermingled normal
cells (Figures 7E and 7F). Further supporting that
OLIG2+ cells are tumor cells, we identified coexpression of
OLIG2 and the terminal neuronal differentiation marker NEUN
in rare cells within human tumors (Figure 7G), and we found
rare OLIG2+ cells that expressed the proliferation marker Ki-67
(Figure 7H). Together, these data suggest the possibility that
some OLIG2+ cells are tumor cells with immature features and
may represent a type of MB progenitor cell.
To mechanistically assess the lineage differentiation potential
of Olig2+ cells in the context of MB, we acutely disassociated tu-
mors from Olig2-tva-cre:SmoM2 mice and infected these cul-
tures with RCAS-GFP viruses to perform fate mapping of tumor
stem/progenitor cells (Figure 7I). In our experimental paradigm,
cells must be Olig2-tva+ for infection with RCAS-GFP to occur.
After 6 days in culture, we found that cells derived from Olig2+
progenitors expressed Pax6, Zic, or NeuN (Figures 7K–7N). Sig-
nificantly, of the 561 GFP+ cells counted, only 68 (12%) ex-
pressed Olig2 on day 6 (Figures 7J and 7N), indicating differen-
tiation along the GC lineage axis with downregulation of Olig2.
Upon acute harvest and disassociation of tumors (day 0), we
found that only 8% expressed Olig2. Of these, 66% coex-
pressed Pax6 and 12% expressed NeuN (Figures 7O–7Q). In
contrast, on day 6 in the tva fate-mapping experiment, 52% of
Olig2-derived progeny expressed NeuN. These data are consis-
tent with the proposal that Olig2+Pax6+ cells lose Olig2 expres-
sion and progress to express the more mature markers such
as Zic and NeuN during the 6 days in culture. We conclude
that Olig2+ cells in Olig2-tva-cre:SmoM2 tumors have the poten-
tial to produce GC-like progeny, therefore supporting the possi-
bility that they represent a subset of MB progenitor cells.
DISCUSSION
Here we show that unipotent CGNPs derive from multilineage
embryonic CNS progenitors and that both populations are capa-
ble of generating MB when targeted with oncogenic SmoM2. De-
spite diverse origins, resulting tumors were similar, leading to the
conclusion that acquisition of CGNP identity is a critical determi-
nant of progenitor cell competence to form Hedgehog-induced128 Cancer Cell 14, 123–134, August 12, 2008 ª2008 Elsevier Inc.
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tions for development of targeted cellular therapies.
Olig2+ Progenitors of the RL Give Rise to a Subset
of Granule Cell Neurons
By creating a knockin transgenic mouse line, Olig2-tva-cre, we
targeted Olig2+ cells using two fate-mapping approaches.
Olig2-tva-cre intercrossed with conditional reporters (e.g.,
ROSA26-YFP) mapped a subset of GCs in the EGL and IGL of
posterior CB. We then confirmed that these cells were derived
from Olig2+ progenitors in the rRL by in utero infection of
Olig2-tva-cre mice with an avian RCAS retrovirus reporter. Al-
though we cannot exclude that Olig2+ cells outside of the rRL
could contribute to CGNPs, this possibility seems unlikely given
previous work that has established the rRL as the source of the
GC lineage. These data indicate that rRL Olig2+ progenitors give
rise to a subset of GCs (Figure S5A) that might contribute to func-
tional heterogeneity (Zong et al., 2005).
Oncogenic Signaling and Lineage-Restricted Factors
Cooperate to Determine Tumor Competence in CNS
Progenitors
Human inherited cancer syndromes exhibit tumor formation in
only a subset of cells within specific lineages despite germline
transmission of tumor-promoting mutations (e.g., p53, pRB
loss of function). Although several reports indicate that the Hh
pathway is active in low- and high-grade gliomas (Ehtesham
Figure 5. Medulloblastoma Generated from Diverse
Progenitor Cell Origins Leads to a Convergent Pheno-
typic Endpoint
(A) Principal component analysis of global gene expression in
conditional MB models (hGFAP- [red], Olig2- [blue], Math1-
[green], Tlx3-cre:SmoM2 [magenta], and Ptc+/ [turquoise])
and samples from normal littermate control CB (black circles)
mapped onto normal cerebellar developmental space as de-
fined by a 7000 member, rank-normalized gene set (Kho
et al., 2004) from developing CB at stages P1, 3, 5, 7, 10,
15, 21, 30, 50, and 60 (orange numbers). Tumors were related
to early rather than late developmental stages of the CB as we
have reported previously for human MB (Kho et al., 2004).
(B) Immunohistochemical analysis confirms that all murine tu-
mors exhibit an immunohistochemical staining pattern similar
to each other as well as human MB with respect to standard
neuronal and glial neuropathological markers. Results are rep-
resentative of at least two tumor samples.
et al., 2007; Clement et al., 2007), in human Goltz-
Gorlin syndrome, inherited heterozygous mutation
of PTC or SUFU leads to MB but not glioma. We
failed to detect gliomas despite robust SmoM2 ac-
tivation in forebrain progenitors, including develop-
ing neural stem cells and persistent progenitors of
the SVZ and cortex expressing GFAP (Doetsch
et al., 1999), NG2/Olig2 (Ligon et al., 2006), and
Gli1 (Machold et al., 2003; Ahn and Joyner, 2005).
Further work is needed to establish whether addi-
tional mutations (e.g., loss of p53) in concert with
Hh activation might be necessary to enable glioma
formation. Another possibility is that Shh activation
biases toward neuronal lineage versus glial differentiation and
therefore a MB phenotype and not glial lineages or glial tumor
phenotype. Although we cannot rule this out, we think that this
explanation is unlikely for the following reasons. First, if one as-
sumes that Shh promotes neuronal tumorigenesis, then one
might expect to see development of such tumors at other CNS
sites (e.g., supratentorial PNETs); this is not observed in human
Goltz-Gorlin syndrome patients or in the mouse models that we
have studied. Second, we did not see other neuronal tumor
types in the CB despite activation of Shh in PNs and INs (Table
1). Third, we have recently shown that SmoM2 activation in the
dentate gyrus causes hypertrophy but not cancer (Han et al.,
2008).
Acquisition of Granule Cell Lineage Identity Is Critical
for Hh-Induced Medulloblastoma Formation
To identify progenitors competent for MB formation, we acti-
vated SmoM2 in a spectrum of stage- and position-specific
progenitors during CGNP development. Both multipotent (e.g.,
hGFAP+ and Olig2+) progenitor populations within the cerebellar
anlage as well as unipotent/restricted CGNPs readily gave rise to
MB with 100% penetrance. Despite these diverse origins, all
SmoM2-activated MBs that we analyzed exhibited a strikingly
similar tumor phenotype at histological, immunohistochemical,
and expression profiling levels. The common final tumor pheno-
type is consistent with (1) a common cell of origin for all tumors or
(2) initial origins from any stem/progenitor that later converge onCancer Cell 14, 123–134, August 12, 2008 ª2008 Elsevier Inc. 129
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Cellular Origins of MedulloblastomaFigure 6. Olig2- and Gfap-Expressing Cells in Medul-
loblastoma Are Neoplastic and Have Features in Com-
mon with Immature Granule Lineage Precursors
(A and C) InMath1-cre:SmoM2animals, morphologic evidence
of hyperplasia is predominantly observed in the EGL—but not
in the RL or VZ—at P0 and is more apparent by P7.
(B and D) Greatly increased numbers of Olig2+ cells are ob-
served in hyperplastic regions of the EGL—but not in the
RL—of P0 and P7 Math1-cre:SmoM2 mice.
(E and F) Expression of Cre proteins inMath1-cremice colocal-
ized with Olig2 at E18, but not at P7.
(G) Olig2 coexpression was detected in only2% of phospho-
H3 (p-H3)+ cells in tumors.
(H) In contrast, 98% of p-H3+ cells colabeled with Cre pro-
teins.
(I–K) Phenotype of acutely disassociated cells and cells cul-
tured from MB for 4 weeks (insets). While most dissociated
Math1-cre:SmoM2 tumor cells express the GC markers Pax6
(I) or NeuN (inset in I), some express Olig2 (J) and Gfap (K).
SmoM2 is fused to YFP, which therefore marks tumor cells.
(L) Cell counting reveals that more than 90% of cells expressing
Gfap, Olig2, and Pax6 are tumor cells, as shown by coexpres-
sion of YFP.
(M and N) Immunohistochemistry of tumor sections demon-
strates similar results.
(O and P) 81% of Olig2+ (O) and 100% of Gfap+ (P) cells in
tumors express the CGNP marker Pax6.an amplifying CGNP-like tumor cell that dominates the ultimate
phenotype (see Figure S5C). In either case, these findings sup-
port the conclusion that acquisition of CGNP identity is important
for Hh-induced MB formation. Because orthotopically trans-
planted Olig2-tva-cre:SmoM2 tumors were able to grow within
the forebrain and CB, restriction of tumor susceptibility is evi-
dently governed by cell-intrinsic factors. Further work is needed
to identify the underlying molecular determinants of CGNP tumor
competence that lead to MB formation.
Hh-Activated Medulloblastoma Can Be Generated
in the EGL Independent of VZ Contributions
Human desmoplastic MB and classic MB have been suggested
to arise from EGL CGNPs (Schu¨ller et al., 2005; Bu¨hren et al.,
2000) and progenitors of the VZ (Salsano et al., 2007; Katsetos
et al., 1995), respectively. Our studies demonstrate that Hh-in-
duced MB can be initiated by precise restriction of activating
mutations to the EGL using Tlx3-cre:SmoM2 and postnatally in-
duced Gli1-creERT2:SmoM2 without activation of SmoM2 in the
less differentiated cell populations of the rRL or VZ. Furthermore,
while the time of tumor onset and the degree of tumor distribu-
tion varied depending on the Cre drivers used (Table 1;
Figure S5B), these variations appear to be based on the number,
extent, and/or location of the total CGNP population targeted
(i.e., broad diffuse versus small lateral populations). In addition,
tumor masses did not develop in the VZ or rRL proper, suggest-
ing that further work will be needed to determine whether addi-
tional oncogenic pathways (e.g., MYC or Wnt) might lead to
MB formation in these regions.
Evidence that Gfap+ and Olig2+ Cells
in Medulloblastomas Are Neoplastic
Our data highlight that both mouse and human MBs exhibit ex-
tensive cellular heterogeneity. GFAP+ cells are commonly identi-130 Cancer Cell 14, 123–134, August 12, 2008 ª2008 Elsevier Inc.fied in human MB (Schu¨ller et al., 2004), and the morphology of
these cells ranges from small tumor cells with a relatively large
nucleus and a sparse, ring-like cytoplasm to cells with a rather
differentiated phenotype and branched processes. We observed
that OLIG2+ cells, present in human MB, also varied in size and
morphology. Using MYC FISH in human MB and YFP tracer ex-
pression in murine MB, we have demonstrated that OLIG2+ and
GFAP+ cells are bona fide tumor cells and not just infiltrating cells
arising from the normal surrounding brain. In addition, we found
small numbers of proliferating Olig2+ and Gfap+ cells within
mouse MB and, to a lesser degree, human MB, further evidence
that these heterogeneous elements represent tumor cells.
In human gliomas, OLIG2 is expressed in tumor stem/progen-
itor cells, and Olig2 maintains the proliferation competence of
both normal and tumorigenic progenitors of the murine forebrain
(Ligon et al., 2007). However, given our data indicating that
OLIG2 is only rarely expressed in proliferating cells and is only
present in 40% of classic and 77% of desmoplastic human
MB cases, it seems clear that MB tumor growth is driven largely
by rapidly dividing progenitor cells with CGNP characteristics
rather than by OLIG2+ cells. Might GFAP+ and OLIG2+ cells in
MB have other roles as relatively quiescent tumor progenitor
cells? Our in vitro tumor fate mapping demonstrates that Hh-
transformed Olig2+ cells from murine MB can produce GC line-
age-like progeny with advanced differentiation as measured by
NeuN labeling. Whether Olig2+ tumor cells from other mouse
models (i.e., non-Olig2-cre-derived) have this capability remains
to be determined.
Our data suggest that GFAP and OLIG2 expression in MB are
not associated with ‘‘differentiated’’ ASs and OLs. While almost
all Gfap+ and Olig2+ cells in Hh-activated murine MB coex-
pressed Pax6 and other CGNP markers, the ‘‘biphenotypic’’
(e.g., OLIG2-NEUN) staining pattern is unlikely to be a specific
consequence of Hh signaling because we also observed this
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Cellular Origins of MedulloblastomaFigure 7. OLIG2 Is Expressed in Human Medulloblas-
toma
(A–D) OLIG2 expression in human classic and desmoplastic
MB (A–C) and percentage of tumors of each class that contain
OLIG2+ cells (D) (see also Table S1).
(E and F) Combined FISH and immunohistochemical analysis
reveals the presence of tumor-specific c-MYC genomic aber-
rations (Herms et al., 2000) within OLIG2+ cells (yellow nuclei)
of human MB (n = 2). c-MYC aberrations were identical in
OLIG2+ and OLIG2 tumor cells. Note combined copy-num-
ber gain (red signals, 50 c-MYC) and structural aberration
(loss of green signals, 30 c-MYC) as detected using a break-
apart probe set. Normal MYC loci show merged colors as
yellow focal signals.
(G and H) OLIG2 colocalizes with NEUN and the proliferation
marker Ki-67.
(I) Scheme for experiments using RCAS-GFP infection of
Olig2-tva-cre:SmoM2 tumor cells.
(J–M) Double-fluorescence images show expression of GFP
that colocalizes with immunoreactivity using antibodies
against Olig2 and GC markers. Note that while Olig2-tva-
cre:SmoM2 cells express YFP, the signal is very weak/unde-
tectable compared with GFP encoded by the RCAS virus.
(N) Summary of findings at day 6 in GFP-labeled cells.
(O–Q) Analysis of acutely disassociated Olig2-tva-cre:SmoM2
tumor cells (day 0). Of Olig2+ cells, 66% colabeled with Pax6
and 12% with NeuN; such cells represented 4% and 1% of
total cells in the tumor, respectively.phenomenon in classic MBs, which are not associated with Hh
mutations (Pietsch et al., 1997). We suggest that GFAP and
OLIG2 label cells with a phenotype reminiscent of radial glia
and less differentiated CGNP progenitors of the rRL (Figure S5A).
Does Medulloblastoma Arise from a Multipotent
Stem Cell?
MB was one of the first solid tumors for which ‘‘cancer stem
cells’’ were reported (Hemmati et al., 2003). Cancer stem cells
are classically described as a tumor subpopulation with (1) un-
limited capacity for self-renewal and the ability to regenerate tu-
mors upon transplantation and (2) the potential to produce multi-
lineage progeny similar to distinct cell types of a cognate organ
(Reya et al., 2001). The question of authentic glial cell production
has critical implications for understanding MB progenitors and
their characterization as multipotent cancer stem cells. How-
ever, evidence for multilineage differentiation of MB stem cells
has been based on the expression of relatively few neuronal
and glial cell markers with uncertain relation to either differenti-
ated cell types of the CB or CNS multipotent stem cells. For ex-
ample, the commonly used marker GFAP marks type B stem
cells of the SVZ (Doetsch et al., 1999). We show that Gfap and
Olig2 mark cells in MBs reminiscent of those found during early
CGNP development, but not differentiated glia. These findings
argue against existence of MB progenitors with multilineage
(neuronal and glial) contributions to tumor mass. However,
they are consistent with the possibility that MB could originate
from either a multipotent or a unipotent progenitor (Figure S5C).We used lineage tracing to clarify the possible relationship be-
tween cells found during GC lineage development and those that
are tumor competent to produce MB. Our findings highlight dis-
tinctions between the ‘‘cell of origin’’ (which acquires the onco-
genic mutation) and ‘‘tumor-propagating’’ cells, responsible for
major growth and phenotypic characteristics of the ultimate tu-
mor. For instance, if unipotent cell identity (‘‘type C2’’) is neces-
sary for tumor growth (Figure S5C), then a tumor arising from mu-
tation of a type A cell or a type C2 cell should appear identical,
notwithstanding their different cells of origin. This also raises
the possibility of a ‘‘dedifferentiation’’ pathway that produces tu-
mors with mixed multipotent and unipotent features, as has been
suggested for certain leukemia stem cells (Krivtsov et al., 2006).
Although our data do not provide direct evidence for dedifferen-
tiation, tumors from postnatally induced Gli1-creERT2:SmoM2
(J.M., A.P.M., and K.L., unpublished data) and Math1-
creERT2:Ptcflox/flox animals (Z.-J. Yang and R.J. Wechsler-
Reya, personal communication) contain many Olig2+ cells, con-
sistent with the possibility that late-stage CGNPs can adopt less
differentiated characteristics (Figure S5). Further investigation is
needed to determine whether dedifferentiation of mature granule
cells (D2/C2; see Figure S5C) constitutes a biologically feasible
or clinically relevant pathway of tumor formation.
EXPERIMENTAL PROCEDURES
Animal Procedures
For fate mapping, various cre strains (Table 1) were intercrossed with
ROSA26-eYFPflox/flox or CAG-CAT-eGFPflox/flox conditional reporter mice. AtCancer Cell 14, 123–134, August 12, 2008 ª2008 Elsevier Inc. 131
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overnight in 4% paraformaldehyde/PBS. For tumor generation, cre strains
were intercrossed with SmoM2flox/flox mice and followed for survival and sub-
sequent Kaplan-Meier analysis. For injections into forebrains or cerebella of
SCID mice, tumor cells were freshly dissociated and resuspended in 1 ml
PBS at a concentration of 105/ml (see Supplemental Experimental Procedures).
See Supplemental Experimental Procedures for detailed information on gener-
ation, acquisition, and genotyping of transgenic mouse strains and procedures
including RCAS infection of Olig2-tva-cre embryonic hindbrain. All animal pro-
cedures were approved by the Institutional Animal Care and Use Committees
of the Dana-Farber Cancer Institute and the University of California, San
Francisco.
Tissue Collection, Histological Analysis, Immunohistochemistry,
In Situ Hybridization, and Photomicroscopy
Human tissue samples were obtained in accordance with the rules and regu-
lations for human tissue collection and use at Children’s Hospital Boston, Brig-
ham and Women’s Hospital/Partners HealthCare, and University Hospital
Mu¨nchen-Großhadern. Tissue samples were processed using standard tech-
niques. Detailed protocols for in situ hybridization, immunohistochemistry, and
immuno-FISH as well as all antibodies used in this study are listed in Supple-
mental Experimental Procedures. Photomicrographs were acquired with Zeiss
Axioskop/Axiocam or Nikon E600/SPOT imaging systems. For whole-mount
images of mouse MBs, fluorescence and bright-field images were overlaid us-
ing Adobe Photoshop software. A Leica TCS SL system was used for confocal
microscopy.
Cell Culture
Cultures from Math1-cre:SmoM2 tumors were established by triturating tumor
tissue in DMEM and plating the cells on poly-D-lysine-coated dishes. Acutely
dissociated Math1-cre:SmoM2 tumor cells were fixed 12 hr after plating.
Long-term cultures were analyzed after 4 weeks in culture and three passages.
Immunostaining was performed as described above. Cells from Olig2-tva-
cre:SmoM2 tumors were infected with virus carrying RCAS(A)-GFP (2 3 107
cfu/ml; gift of C. Cepko, Harvard Medical School) after 24 hr culture in se-
rum-free medium. Serum-containing medium was then added, and after a total
culture time of 6 days, cells were fixed and stained.
Statistics and Quantification
For in vivo fate mapping in Olig2-tva-cre mice, counts were derived from anal-
yses of three independent animals and at least ten 203 fields of labeled sec-
tions of CB focused around lobe X. For cell culture counts, cells were derived
from pups from at least four separate litters. Each litter yielded material for two
six-well plates of cerebellar cultures and one six-well plate of ventricular cul-
tures. EGF, Shh, and vehicle were each applied to three 3.5 cm culture wells.
At least 100 cells were assessed in each sample to determine the fraction
of Olig2+, Zic+, and Gfap+ cells. Statistical analysis was performed using
Student’s unpaired t test with a two-tailed p value.
Microarray Data and Analysis
The transcriptomes of 21 Cre-activated tumors and control cerebellar tissues
were profiled using the Affymetrix GeneChip Mouse Genome 430 2.0 Plus ar-
ray. Transcriptomes of the P1–60 developing mouse CB were profiled using
the Affymetrix Murine Mu11K set as described previously (Kho et al., 2004),
and principal component analysis was used to determine the global similarity
and variation between the transcriptome profiles of the different tissues (John-
son and Wichern, 2002). For detailed description, see Supplemental Experi-
mental Procedures.
ACCESSION NUMBERS
Microarray data have been deposited in the NCBI Gene Expression Omnibus
(http://www.ncbi.nlm.nih.gov/geo/) with the accession number GSE11859.132 Cancer Cell 14, 123–134, August 12, 2008 ª2008 Elsevier Inc.SUPPLEMENTAL DATA
The Supplemental Data include Supplemental Experimental Procedures,
Supplemental References, one table, and five figures and can be found with
this article online at http://www.cancercell.org/cgi/content/full/14/2/123/
DC1/.
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